Neuroendocrine Neoplasms

• CLINICAL_TRIALS trial_result · 2025-09-05
  Clinical Trial Update: A Clinical Study of Lutetium[177Lu] Oxodotreotide Injection in Patients With Advanced Neuroendocrine Neoplasms [Phase 2, Phase 3]

  This is a clinical trial update for a Phase 2/3 study of Lutetium-177 DOTATATE in patients with advanced neuroendocrine neoplasms.

• CLINICAL_TRIALS trial_result · 2022-02-17
  Clinical Trial Update: Al18F-NOTA-octreotide PET Imaging in Neuroendocrine Tumors [Phase 2, Phase 3]

  Phase 2/3 trial investigating Al18F-NOTA-octreotide PET imaging for neuroendocrine tumors has completed.

• CLINICAL_TRIALS trial_result · 2020-09-09
  Clinical Trial Update: Study of Mutation-Targeted Therapy With Sunitinib or Everolimus in People With Advanced Low- or Intermediate-Grade Neuroendocrine Tumors of the Gastrointestinal Tract and Pancreas With or Without Cytoreductive Surgery [Phase 2]

  Phase 2 trial evaluating mutation-targeted therapy with sunitinib or everolimus in advanced low- or intermediate-grade neuroendocrine tumors…